Patent Yard Sign in
Expired Canadian patentCanada

Device for inserting a nasal tube

CA 1295905 C · Owner: Augustine Medical, Inc. · Inventors: Augustine, Scott D.; Augustine, Douglas J.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A device for inserting a nasal tube through the nose into the oropharynx. The device includes an elongate collapsible sleeve to which is attached an elongate relatively slender arcuate member along a longitudinal dimension of the sleeve. A soft, blunt distal tip is formed on the arcuate member and juts beyond the distal end of the sleeve. Prior to insertion in the nasal cavity the distal, end of the sleeve is sealed. The device is inserted distal, tip first, through the nasal cavity and nasopharynx so that the distal tip extends into the oropharynx. The curvature of the arcuate member enables the device to round the corner at the rear of the nasopharynx. Once the device is in place, a tube …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 18, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 18, 2009.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 15, 1988
GrantedFebruary 18, 1992
Term endedFebruary 18, 2009
Patent numberCA 1295905 C
Classification (IPC)A61M16/00 +1 more

Timeline

Timeline From CIPO dates

1989199219951998200120042007Application filedJan 15, 1988Patent grantedFeb 18, 1992Term endedFeb 18, 2009

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.